Copyright
©The Author(s) 2025.
World J Gastroenterol. Jul 14, 2025; 31(26): 109500
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.109500
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.109500
Figure 3 Validation of hsa-let-7f-5p expression by reverse transcription-quantitative polymerase chain reaction.
A: Amplification curve of hsa-let-7f-5p from transcription-quantitative polymerase chain reaction analysis; B: Validation results showing the relative expression of serum exosomal hsa-let-7f-5p in patients with metastatic and non-metastatic pancreatic cancer.
- Citation: Ren S, Song LN, Zhao R, Tian Y, Wang ZQ. Serum exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. World J Gastroenterol 2025; 31(26): 109500
- URL: https://www.wjgnet.com/1007-9327/full/v31/i26/109500.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i26.109500